-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer, with a high incidence in East and Southeast Asia and rising
The researchers retrospectively evaluated clinical data
The results showed that in both the original and matched cohorts, the total lifetime and recurrence-free survival (OS) of the CCBs group were significantly longer than those of the OS in the non-CCBs group (98 months vs 45 months, p = 0.
This study confirms that CCB can improve disease prognosis after resection in ICC patients, and the mechanism may be related to CCB not only acting directly on cancer cells, but also affecting these related
Original Source:
Kenichiro Kodama.